Compare IBRX & OMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBRX | OMF |
|---|---|---|
| Founded | 2014 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.6B |
| IPO Year | 2015 | 2013 |
| Metric | IBRX | OMF |
|---|---|---|
| Price | $9.17 | $60.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $12.57 | ★ $66.75 |
| AVG Volume (30 Days) | ★ 11.7M | 968.7K |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 7.25% |
| EPS Growth | 38.71 | ★ 54.72 |
| EPS | N/A | ★ 1.93 |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $88.59 | $66.43 |
| Revenue Next Year | $131.15 | $6.97 |
| P/E Ratio | ★ N/A | $31.28 |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $45.78 |
| 52 Week High | $12.43 | $71.93 |
| Indicator | IBRX | OMF |
|---|---|---|
| Relative Strength Index (RSI) | 70.92 | 63.09 |
| Support Level | $6.69 | $55.93 |
| Resistance Level | $9.54 | $61.16 |
| Average True Range (ATR) | 0.55 | 1.51 |
| MACD | 0.23 | 0.39 |
| Stochastic Oscillator | 90.94 | 74.37 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.